← Evidence map

ArticleNeurology2024

Validation of the RBD Symptom Severity Scale in the North American Prodromal Synucleinopathy Consortium.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 38662993